Marc Fellous

4.9k total citations · 1 hit paper
111 papers, 3.9k citations indexed

About

Marc Fellous is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Fellous has authored 111 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 35 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Fellous's work include T-cell and B-cell Immunology (22 papers), Immune Cell Function and Interaction (21 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Marc Fellous is often cited by papers focused on T-cell and B-cell Immunology (22 papers), Immune Cell Function and Interaction (21 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Marc Fellous collaborates with scholars based in France, United States and Germany. Marc Fellous's co-authors include Sandra Pellegrini, Laura Evelia Torres Velázquez, George R. Stark, Michel Revel, David Wallach, Joëlle Wiels, Gilles Uzé, K. E. Mogensen, Giovanna Barbieri and Ken McElreavey and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marc Fellous

107 papers receiving 3.7k citations

Hit Papers

A protein tyrosine kinase in the interferon αβ signaling ... 1992 2026 2003 2014 1992 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A protein tyrosine kinase in the interferon αβ signaling pathway
    1992 753 citations Laura Evelia Torres Velázquez, Marc Fellous et al. profile →

Peers

Marc Fellous
Tapan K. Bera United States
Harald S. Haugen United States
Barry M. Kacinski United States
C. M. Steel United Kingdom
Stefan Einhorn Sweden
George Kannourakis Australia
Claude Perreault Canada
Charles E. Egwuagu United States
Claudine Rancourt Canada
Akio Matsuzawa Japan
Tapan K. Bera United States
Marc Fellous
Citations per year, relative to Marc Fellous Marc Fellous (= 1×) peers Tapan K. Bera

Countries citing papers authored by Marc Fellous

Since Specialization
Citations

This map shows the geographic impact of Marc Fellous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Fellous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Fellous more than expected).

Fields of papers citing papers by Marc Fellous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Fellous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Fellous. The network helps show where Marc Fellous may publish in the future.

Co-authorship network of co-authors of Marc Fellous

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Fellous. A scholar is included among the top collaborators of Marc Fellous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Fellous. Marc Fellous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schram, Alison M., Gilberto Lopes, Elisa Fontana, et al.. (2024). 691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation. Annals of Oncology. 35. S535–S536. 2 indexed citations
2.
Yang, James Chih‐Hsin, Marcia S. Brose, Gilberto de Castro, et al.. (2022). Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib. BMC Cancer. 22(1). 625–625. 8 indexed citations
3.
Bridgewater, John, Xiaolong Jiao, Clare Flach, et al.. (2022). Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer Treatment and Research Communications. 33. 100623–100623. 6 indexed citations
4.
Bazhenova, Lyudmila, Jeremy Snider, Emily Castellanos, et al.. (2021). TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting. Targeted Oncology. 16(3). 389–399. 34 indexed citations
5.
Leyvraz, Serge, James Chih‐Hsin Yang, Paolo G. Casali, et al.. (2020). 604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer. Annals of Oncology. 31. S503–S503. 2 indexed citations
6.
Italiano, Antoîne, David S. Hong, Andrew Briggs, et al.. (2020). 542P Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients. Annals of Oncology. 31. S473–S474. 3 indexed citations
7.
8.
9.
Dipietromaria, Aurélie, Sandrine Caburet, Ottavia Barbieri, et al.. (2011). Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency. Human Molecular Genetics. 20(13). 2642–2650. 18 indexed citations
10.
Laissue, Paul, et al.. (2008). Analyse génétique des insuffisances ovariennes prématurées : implication des gènes forkhead et TGF-β. Gynécologie Obstétrique & Fertilité. 36(9). 862–871. 1 indexed citations
11.
Kamitani, Tetsu, Xue-Jun Yang, Laura C. Bridgewater, et al.. (2004). The transcription factor Sox9 is degraded by the ubiquitin?proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biology. 23(8). 499–505. 54 indexed citations
12.
Richter, Marc François, Guillaume Duménil, Gilles Uzé, Marc Fellous, & Sandra Pellegrini. (1998). Specific Contribution of Tyk2 JH Regions to the Binding and the Expression of the Interferon α/β Receptor Component IFNAR1. Journal of Biological Chemistry. 273(38). 24723–24729. 78 indexed citations
13.
McElreavey, Ken & Marc Fellous. (1997). Sex-Determining Genes. Trends in Endocrinology and Metabolism. 8(9). 342–346. 17 indexed citations
14.
Duménil, Guillaume, Michele Rubini, G C Dubois, et al.. (1997). Identification of Signalling Components in Tyrosine Kinase Cascades Using Phosphopeptide Affinity Chromatography. Biochemical and Biophysical Research Communications. 234(3). 748–753. 4 indexed citations
15.
Ottone, Catherine, Ad Peijnenburg, Frédéric Colland, et al.. (1996). The RAG cell line defines a new complementation group of MHC class II deficiency. Immunogenetics. 43(6). 352–359. 7 indexed citations
16.
Barbieri, Giovanna, et al.. (1994). Activation of the protein tyrosine kinase tyk2 by interferon α/β. European Journal of Biochemistry. 223(2). 427–435. 52 indexed citations
17.
Mossalayi, M. Djavad, et al.. (1985). Agar human T cell colony growth promoted by a B + null cell-derived lymphokine distinct from IL 2.. The Journal of Immunology. 134(4). 2400–2404. 14 indexed citations
18.
Crevat, Denis, Jorge Kalil, Frédéric Rosa, & Marc Fellous. (1983). [Presence of 2 different epitopes on the human beta 2-microglobulin defined by monoclonal antibodies].. PubMed. 134C(1). 31–41. 5 indexed citations
19.
Fellous, Marc, et al.. (1981). Interferon enhances the amount of membrane‐bound β2‐microglobulin and its release from human Burkitt cells. European Journal of Immunology. 11(6). 524–526. 28 indexed citations
20.
Erickson, Robert P., Gabriel Gachelin, Marc Fellous, & F Jacob. (1977). ABSORPTION ANALYSIS OF H‐2D AND K ANTIGENS ON SPERMATOZOA. International Journal of Immunogenetics. 4(1). 47–51. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tapan K. Bera Breakdown of academic impact, for papers by Harald S. Haugen Breakdown of academic impact, for papers by Barry M. Kacinski Breakdown of academic impact, for papers by C. M. Steel Breakdown of academic impact, for papers by Stefan Einhorn Breakdown of academic impact, for papers by George Kannourakis Breakdown of academic impact, for papers by Claude Perreault Breakdown of academic impact, for papers by Charles E. Egwuagu Breakdown of academic impact, for papers by Claudine Rancourt Breakdown of academic impact, for papers by Akio Matsuzawa
Rankless by CCL
2026